These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2981223)

  • 1. Localization of tyrosine kinase-coding region in v-abl oncogene by the expression of v-abl-encoded proteins in bacteria.
    Wang JY; Baltimore D
    J Biol Chem; 1985 Jan; 260(1):64-71. PubMed ID: 2981223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An E. coli expression system for the rapid purification and characterization of a v-abl tyrosine protein kinase.
    Lydon NB; Adams B; Poschet JF; Gutzwiller A; Matter A
    Oncogene Res; 1990; 5(3):161-73. PubMed ID: 2157186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The minimum transforming region of v-abl is the segment encoding protein-tyrosine kinase.
    Prywes R; Foulkes JG; Baltimore D
    J Virol; 1985 Apr; 54(1):114-22. PubMed ID: 2983108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and analysis of an Abelson murine leukemia virus-encoded tyrosine-specific kinase produced in Escherichia coli.
    Ferguson B; Pritchard ML; Feild J; Rieman D; Greig RG; Poste G; Rosenberg M
    J Biol Chem; 1985 Mar; 260(6):3652-7. PubMed ID: 2982873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A membrane-associated, carbohydrate-modified form of the v-abl protein that cannot be phosphorylated in vivo or in vitro.
    Watanabe SM; Rosenberg NE; Witte ON
    J Virol; 1984 Sep; 51(3):620-7. PubMed ID: 6088787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and function of the Abelson murine leukemia virus transforming gene.
    Wang JY; Prywes R; Baltimore D
    Prog Clin Biol Res; 1983; 119():57-63. PubMed ID: 6306691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insertional mutagenesis of the Abelson murine leukemia virus genome: identification of mutants with altered kinase activity and defective transformation ability.
    Rees-Jones RW; Goff SP
    J Virol; 1988 Mar; 62(3):978-86. PubMed ID: 2828693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A truncated v-abl-derived tyrosine-specific tyrosine kinase expressed in Escherichia coli.
    Pritchard ML; Rieman D; Feild J; Kruse C; Rosenberg M; Poste G; Greig RG; Ferguson BQ
    Biochem J; 1989 Jan; 257(2):321-9. PubMed ID: 2539083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity.
    Reddy EP; Smith MJ; Srinivasan A
    Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3623-7. PubMed ID: 6304726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of a protein-tyrosine kinase encoded by the Abelson murine leukemia virus.
    Foulkes JG; Chow M; Gorka C; Frackelton AR; Baltimore D
    J Biol Chem; 1985 Jul; 260(13):8070-7. PubMed ID: 2989275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity.
    Engelman A; Rosenberg N
    J Virol; 1990 Sep; 64(9):4242-51. PubMed ID: 1696637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the c-abl oncogene by viral transduction or chromosomal translocation generates altered c-abl proteins with similar in vitro kinase properties.
    Davis RL; Konopka JB; Witte ON
    Mol Cell Biol; 1985 Jan; 5(1):204-13. PubMed ID: 4039028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity.
    Kloetzer W; Kurzrock R; Smith L; Talpaz M; Spiller M; Gutterman J; Arlinghaus R
    Virology; 1985 Jan; 140(2):230-8. PubMed ID: 2982232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of an Abelson murine leukemia virus-encoded protein in Escherichia coli causes extensive phosphorylation of tyrosine residues.
    Wang JY; Queen C; Baltimore D
    J Biol Chem; 1982 Nov; 257(22):13181-4. PubMed ID: 6292177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of murine c-abl protooncogene: effect of a point mutation on oncogenic activation.
    Shore SK; Bogart SL; Reddy EP
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6502-6. PubMed ID: 2168550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservation of function of Drosophila melanogaster abl and murine v-abl proteins in transformation of mammalian cells.
    Holland GD; Henkemeyer MJ; Kaehler DA; Hoffmann FM; Risser R
    J Virol; 1990 May; 64(5):2226-35. PubMed ID: 2157882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. bcr/abl and src but not myc and ras replace v-abl in lymphoid transformation.
    Engelman A; Rosenberg N
    Mol Cell Biol; 1990 Aug; 10(8):4365-9. PubMed ID: 2164639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies specific for v-abl- and c-abl-encoded molecules.
    Schiff-Maker L; Burns MC; Konopka JB; Clark S; Witte ON; Rosenberg N
    J Virol; 1986 Mar; 57(3):1182-6. PubMed ID: 3005619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of temperature-sensitive tyrosine kinase mutants of v-abl oncogene by screening with antibodies for phosphotyrosine.
    Kipreos ET; Lee GJ; Wang JY
    Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1345-9. PubMed ID: 2434953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abelson transformed fibroblasts lacking the EGF receptor are not tumourigenic in nude mice.
    Gebhardt A; Bell JC; Foulkes JG
    EMBO J; 1986 Sep; 5(9):2191-5. PubMed ID: 3023060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.